AGIO

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Agios Pharm

NASDAQ | AGIO

27.13

USD

$0.00

(

0.00%

)

At Close (As of Dec 15, 2025)

$1.59B

Market Cap

-

P/E Ratio

-7.01

EPS

$46.00

52 Week High

$22.24

52 Week Low

HEALTHCARE

Sector

AGIO Chart

Recent Chart
Price Action

AGIO Technicals

Tags:

AGIO Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $32M
Total Revenue $36M
Cost Of Revenue $4.2M
Costof Goods And Services Sold $4.2M
Operating Income -$426M
Selling General And Administrative $157M
Research And Development $301M
Operating Expenses $458M
Investment Income Net -
Net Interest Income $48M
Interest Income $48M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $5.7M
Income Before Tax $718M
Income Tax Expense $44M
Interest And Debt Expense -
Net Income From Continuing Operations $674M
Comprehensive Income Net Of Tax -
Ebit -$426M
Ebitda -$420M
Net Income $674M

Revenue & Profitability

Earnings Performance

AGIO Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $1.7B
Total Current Assets $966M
Cash And Cash Equivalents At Carrying Value $76M
Cash And Short Term Investments $76M
Inventory $28M
Current Net Receivables $4.1M
Total Non Current Assets $698M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $638M
Short Term Investments $817M
Other Current Assets $40M
Other Non Current Assets -
Total Liabilities $122M
Total Current Liabilities $81M
Current Accounts Payable $17M
Deferred Revenue -
Current Debt -
Short Term Debt $17M
Total Non Current Liabilities $41M
Capital Lease Obligations $57M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $57M
Other Current Liabilities $47M
Other Non Current Liabilities $880K
Total Shareholder Equity $1.5B
Treasury Stock -
Retained Earnings -$149M
Common Stock $73K
Common Stock Shares Outstanding $58M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$390M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $5.7M
Capital Expenditures $1.7M
Change In Receivables -
Change In Inventory -$8.5M
Profit Loss -
Cashflow From Investment $363M
Cashflow From Financing $14M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $674M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $32M
Total Revenue $36M
Cost Of Revenue $4.2M
Costof Goods And Services Sold $4.2M
Operating Income -$426M
Selling General And Administrative $157M
Research And Development $301M
Operating Expenses $458M
Investment Income Net -
Net Interest Income $48M
Interest Income $48M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $5.7M
Income Before Tax $718M
Income Tax Expense $44M
Interest And Debt Expense -
Net Income From Continuing Operations $674M
Comprehensive Income Net Of Tax -
Ebit -$426M
Ebitda -$420M
Net Income $674M

AGIO News

AGIO Profile

Agios Pharm Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Agios Pharmaceuticals, Inc. is a prominent biopharmaceutical company headquartered in Cambridge, Massachusetts, dedicated to developing transformative therapies targeting diseases related to cellular metabolism. With a strong focus on oncology and rare genetic disorders, Agios utilizes its extensive knowledge of metabolic pathways to create innovative treatments that exemplify precision medicine. The company boasts a promising pipeline and actively engages in strategic collaborations to enhance research and development efforts, demonstrating its commitment to advancing scientific understanding and significantly improving patient outcomes through state-of-the-art therapeutic solutions.

LPTX
+368.57%
$2.05
WOK
+14.44%
$0.12
OCG
-13.77%
$0.18
YGMZ
-61.42%
$0.02
AXDX
-61.36%
$0.03
ASBP
-9.09%
$0.09
IRBT
-68.51%
$1.36
ADAP
-15.14%
$0.05
AAL
0.00%
$14.96
PAVS
-13.86%
$0.03
WBD
+1.66%
$29.98
VHAI
0.00%
$0.00
UGRO
+38.07%
$0.33
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
SNAP
-4.31%
$7.31
ASST
-8.94%
$0.78
ADD
-25.47%
$0.05
IVP
-12.42%
$0.04
AMD
-4.80%
$210.78
GOOGL
-1.00%
$309.29
CRWV
-10.05%
$78.59
TSLA
+3.72%
$476.07
SRM
+53.27%
$10.30
RIG
-3.50%
$4.13
QBTS
-6.71%
$26.10
NIO
-1.94%
$5.03
CIFR
-9.69%
$17.05
RGTI
-3.86%
$25.84
TWOH
-7.69%
$0.00
SMR
-13.57%
$18.34
BBD
+1.17%
$3.45
CMG
+3.64%
$36.14
MIST
-18.30%
$2.41
NVDA
+1.31%
$177.31
SOUN
-3.15%
$11.65
ABEV
+2.00%
$2.55
YCBD
+12.08%
$1.34
JBLU
+1.02%
$4.94
CGC
-1.35%
$1.71
HL
-2.79%
$18.81
KIND
-14.44%
$2.37
IBRX
+7.76%
$2.36
NOK
-1.41%
$6.27
AG
-5.17%
$15.94
BTBT
-8.53%
$2.25
AFMD
-34.94%
$0.18
SMCI
-4.96%
$32.33
NCLH
+1.50%
$20.86
FISV
+0.86%
$68.75
FI
+0.86%
$68.75
GPUS
-7.85%
$0.26
LUV
+1.05%
$41.17
ASTS
-9.49%
$76.70
SNDL
+24.85%
$2.21
ONDS
-11.67%
$7.72
GRYP
-10.38%
$1.38
JOBY
-4.56%
$14.85
MODV
-25.22%
$0.43
KO
+2.04%
$70.52
QUBT
-6.07%
$12.05
RXRX
-5.45%
$4.33
BLNK
-12.06%
$0.77
KEY
-0.14%
$20.66
NAKA
-7.79%
$0.40
KDLY
-7.79%
$0.40
FCX
-1.51%
$47.38
IXHL
+3.72%
$0.42
EXK
-4.56%
$8.98
KDP
+0.13%
$29.51
AMCR
-1.20%
$8.23
CCL
-0.79%
$27.62
ATPC
-8.08%
$0.12
UBER
-0.38%
$85.11
TSLG
+5.34%
$10.45
IREN
-10.26%
$36.01
AVGO
-3.63%
$346.83
CLSK
-15.43%
$11.86
BITF
-8.02%
$2.52
SHOT
-74.37%
$0.39
TLRY
-2.63%
$11.83
BTE
-0.32%
$3.03
ZAPP
-46.30%
$0.15
SCHW
-0.41%
$96.65
CCCS
+6.37%
$7.68
APH
-7.08%
$129.24
MCHP
-2.76%
$67.18
DIS
+0.12%
$111.60
RDW
-4.95%
$7.29
YMM
-0.50%
$11.76
CORZ
-5.00%
$16.53
WFC
+0.18%
$92.76
URG
+2.40%
$1.28
ROIV
+3.56%
$22.10
NVO
-0.21%
$50.18
BYSI
-3.21%
$2.11
HAL
-1.71%
$28.62
AGNC
+0.19%
$10.32
FOLD
+6.56%
$10.55
LPTX
+368.57%
$2.05
WOK
+14.44%
$0.12
OCG
-13.77%
$0.18
YGMZ
-61.42%
$0.02
AXDX
-61.36%
$0.03
ASBP
-9.09%
$0.09
IRBT
-68.51%
$1.36
ADAP
-15.14%
$0.05
AAL
0.00%
$14.96
PAVS
-13.86%
$0.03
WBD
+1.66%
$29.98
VHAI
0.00%
$0.00
UGRO
+38.07%
$0.33
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
SNAP
-4.31%
$7.31
ASST
-8.94%
$0.78
ADD
-25.47%
$0.05
IVP
-12.42%
$0.04
AMD
-4.80%
$210.78
GOOGL
-1.00%
$309.29
CRWV
-10.05%
$78.59
TSLA
+3.72%
$476.07
SRM
+53.27%
$10.30
RIG
-3.50%
$4.13
QBTS
-6.71%
$26.10
NIO
-1.94%
$5.03
CIFR
-9.69%
$17.05
RGTI
-3.86%
$25.84
TWOH
-7.69%
$0.00
SMR
-13.57%
$18.34
BBD
+1.17%
$3.45
CMG
+3.64%
$36.14
MIST
-18.30%
$2.41
NVDA
+1.31%
$177.31
SOUN
-3.15%
$11.65
ABEV
+2.00%
$2.55
YCBD
+12.08%
$1.34
JBLU
+1.02%
$4.94
CGC
-1.35%
$1.71
HL
-2.79%
$18.81
KIND
-14.44%
$2.37
IBRX
+7.76%
$2.36
NOK
-1.41%
$6.27
AG
-5.17%
$15.94
BTBT
-8.53%
$2.25
AFMD
-34.94%
$0.18
SMCI
-4.96%
$32.33
NCLH
+1.50%
$20.86
FISV
+0.86%
$68.75
FI
+0.86%
$68.75
GPUS
-7.85%
$0.26
LUV
+1.05%
$41.17
ASTS
-9.49%
$76.70
SNDL
+24.85%
$2.21
ONDS
-11.67%
$7.72
GRYP
-10.38%
$1.38
JOBY
-4.56%
$14.85
MODV
-25.22%
$0.43
KO
+2.04%
$70.52
QUBT
-6.07%
$12.05
RXRX
-5.45%
$4.33
BLNK
-12.06%
$0.77
KEY
-0.14%
$20.66
NAKA
-7.79%
$0.40
KDLY
-7.79%
$0.40
FCX
-1.51%
$47.38
IXHL
+3.72%
$0.42
EXK
-4.56%
$8.98
KDP
+0.13%
$29.51
AMCR
-1.20%
$8.23
CCL
-0.79%
$27.62
ATPC
-8.08%
$0.12
UBER
-0.38%
$85.11
TSLG
+5.34%
$10.45
IREN
-10.26%
$36.01
AVGO
-3.63%
$346.83
CLSK
-15.43%
$11.86
BITF
-8.02%
$2.52
SHOT
-74.37%
$0.39
TLRY
-2.63%
$11.83
BTE
-0.32%
$3.03
ZAPP
-46.30%
$0.15
SCHW
-0.41%
$96.65
CCCS
+6.37%
$7.68
APH
-7.08%
$129.24
MCHP
-2.76%
$67.18
DIS
+0.12%
$111.60
RDW
-4.95%
$7.29
YMM
-0.50%
$11.76
CORZ
-5.00%
$16.53
WFC
+0.18%
$92.76
URG
+2.40%
$1.28
ROIV
+3.56%
$22.10
NVO
-0.21%
$50.18
BYSI
-3.21%
$2.11
HAL
-1.71%
$28.62
AGNC
+0.19%
$10.32
FOLD
+6.56%
$10.55
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.